Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trials Support Service Market Growth Forecast Analysis Report 2030
... restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Clinical Trials Support Service market size is ... Read More
-
Clinical Trials Outsourcing Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Clinical Trials Outsourcing market size is growing at ... Read More
-
Eosinophilic Esophagitis
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Global Nasopharyngeal Cancer Market - 2022-2029
... % during the forecast period (2022-2029). Nasopharyngeal cancer is a rare therapy of malignant cancer that appears in the nasopharynx. It is the upper part of the throat behind the nose. The nasopharynx is situated ... Read More
-
Global Bronchiectasis Treatment Market - 2022-2029
... 6.0% during the forecast period (2022-2029). Bronchiectasis is a condition affecting the airways in the lungs that causes cough, increased mucus production, and recurrent lung infections. The symptoms are caused by abnormal widening of the ... Read More
-
Global Phenylketonuria Treatment Market - 2022-2029
... accumulates the amino acid phenylalanine. PKU is caused by a mutation in a gene that aids in the production of the phenylalanine-degrading enzyme. Seizures, mental illnesses, and other untreated disorders can result from an excess ... Read More
-
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 10.7 million diagnosed prevalent cases of axSpA across 16 pharmaceutical markets. Currently there are eight leading marketed drugs for the treatment of axSpA, and AbbVie is a key player in the disease ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
... these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Studies suggest that around 40% of the total investment made for the development of a drug ... Read More
-
Clinical Trials Management System Market Research Report 2022-2030
... trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Clinical ... Read More
-
Artificial Intelligence Based Clinical Trials Solution Provider Market Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030
... data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. ... Read More
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 260.6 million diagnosed prevalent cases of Asthma across 16 pharmaceutical markets. GSK is a key player in the disease space with four key products for asthma. Other main players include AstraZeneca, with two products, ... Read More
-
Global Glioblastoma Multiforme Market - 2022-2029
... nervous system tumor. Globally, GBM accounts for 54% of new gliomas and 45% of primary malignant tumors. GBM can be either intra tentorial (area located below tentorium cerebella) or supratentorial (area located above the tentorium ... Read More
-
Global Neuroendocrine Cancer Market - 2022-2029
... during the forecast period (2022-2029). Neuroendocrine tumors are tumors that start in specialized neuroendocrine cells. Nerve cells and hormone-producing cells share characteristics with neuroendocrine cells. Market Dynamics The increasing research and development and the growing ... Read More
-
Global Skin Cancer Market - 2022-2029
... to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly due to solar and artificial ultraviolet radiation (UV). Ultraviolet radiation is a primary carcinogen that results in UV-induced ... Read More
-
Netherton Syndrome
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
Global Red Biotechnology Market - 2022-2029
... 5.2% during the forecast period (2022-2029). Red biotechnology indicates biopharmaceuticals. It involves the use of biotechnology in the medical field. It covers applications of biotechnology relating to clinical trials, vaccine development, disease research, antibiotic production, ... Read More
-
Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Treatment Studies and Observational Studies), by Medical Condition (Neuropsychiatric Conditions, Infectious Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pediatric clinical trials ... Read More
-
Clinical Trials - The Movement Towards Decentralized Clinical Trials
... is the top virtual component used Scope The clinical trial data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The report focuses on DCT trials that were initiated between 2001 to 2022. ... Read More
-
Middle East & Africa Pharma ADMET Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others)
... (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others) The pharma ADMET testing market in Middle East & Africa is expected to grow from US$ ... Read More
-
North America Pharma ADMET Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others)
... High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others) The pharma ADMET testing market in North America is expected to grow from US$ 2,998.33 million in 2022 ... Read More
-
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021
... company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
... Component [Datasets (Clinical, Claims, Pharmacy), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029 The U.S. RWE solutions market is expected to grow at a CAGR of ... Read More
-
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape
... be more than 36.000 diagnosed incidence cases of Autoimmune Hepatitis across 16 pharmaceutical markets. No FDA-approved marketed drugs are available for Autoimmune Hepatitis. However, there are several treatments used off-label to manage Autoimmune Hepatitis. Among ... Read More
-
AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
... Growth & Trends The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast ... Read More
-
Global Clinical Trial Management Systems (CTMS) Market 2022 - Snapshot
... reach ~USD 2,035 million by 2028, according to a new report by Gen Consulting Company. This industry report offers market estimates of the global market, followed by a detailed analysis of the product, deployment mode, ... Read More
Research Assistance
